Deprenyl Animal Health Inc. regulatory update

DAHI's Anipryl (l-deprenyl) received Canadian approval to treat Cushing's disease, a canine endocrine disorder. The approved dosage formulations are 2 mg, 5 mg and 15 mg. The Overland Park, Kan., comp...